Nrf2 is aberrantly overexpressed in many cancers, and one reason for this is the presence of mutations in Keap1, the ligase targeting Nrf2 (Shibata et al., 2008b; Yoo et al., 2012). The gene discussed is NFE2L2; the disease is cancer.